Symptoms of very large overdosage are nausea and vomiting. Guaifenesin is, however, rapidly metabolised and excreted in the urine. Patients should be kept under observation and treated symptomatically.
36 months.
Hypersensitivity to the active ingredients or to any of the excipients.
Not to be used in children under 6 years of age.
None.
Sodium benzoate
Sodium saccharin
Glycerol
Sorbital solution (70%) (Non-cryst)
Citric acid monohydrate or anhydrous citric acid
Blackcurrant flavour DA13624
Vanilla flavour NN21166
Acesulfame Potassium
Hydroxyethylcellulose
Purified water
Linctus
A clear, colourless or straw coloured solution
The following side effects may be associated with the use of guaifenesin:
Gastro-intestinal Disorders: nausea, vomiting
Immune System Disorders: hypersensitivity reactions
None.
Expectorant for the symptomatic relief of acute productive (chesty) cough.
The linctus is for the lubrication and relief of the sore throat and hoarseness, which may be associated with the cough.
Guaifenesin is reported to reduce the viscosity of tenacious sputum and is used as an expectorant.
Guaifenesin is readily absorbed from the gastrointestinal tract. It is readily metabolised and excreted in the urine. It has a plasma half life of 1 hour.
25 July 2013
Tixylix® Chesty Cough
Novartis Consumer Health UK Limited
Park View,
Riverside Way,
Watchmoor Park,
Camberley,
Surrey,
GU15 3YL
Trading as: Novartis Consumer Health
Store below 25°C.
| Container: | Amber glass bottles |
| Closure: | Wadded, aluminium roll-on pilfer-proof closure (ROPP) or Wadded, polypropylene or polypropylene/HDPE child resistant tamper evident closure |
| Wad: | PVdC-coated. Board or EPE |
Each bottle contains 100 ml or 150ml.
PL 00030/0082
Each 5ml contains Guaifenesin 50mg
Consult a doctor before use if suffering from an acute asthma attack, a chronic cough or are asthmatic.
Stop use and consult a healthcare professional if the cough persists for longer than 5 days.
Stop use and consult a healthcare professional if the cough is accompanied by a fever, rash or persistent headache or is recurrent.
If symptoms persist, consult a doctor.
Keep out of the sight and reach of children.
Do not exceed the stated dose.
Do not take with any other cough and cold medicine, including cough suppressants.
None.
The following dose is taken 4 hourly. Do not exceed 6 doses in 24 hours.
Tixylix Chesty Cough is contra-indicated in children under 6 years of age.
6 - 10 years 5 to 10ml
Not to be used for more than 5 days without the advice of a doctor. Parents or carers should seek medical advice if the child's condition deteriorates during treatment.
Do not exceed the stated dose.
Keep out of the sight and reach of children.
Keep all medicines out of the reach of children.
Granted: 1 August 1997
